We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Company to Promote Use of Cardiac PET

By HospiMedica staff writers
Posted on 16 Jun 2006
The Bracco Group (Milan, Italy), a developer of diagnostic imaging systems, and Integrated Medical Solutions, LLC (Sterling, VA, USA), a provider of positron emission tomography (PET) imaging centers in the United States, have formed a new company, Integrated Cardiac Solutions, LLC (ICS; Alexandria, VA, USA). More...
ICS will provide turnkey services that enable outpatient cardiology groups and heart centers to implement cardiac PET perfusion imaging technology for the detection of cardiovascular disease.

"The formation of ICS will lead an evolution in the field of cardiology,” said Carlo Medici, president and CEO of Bracco Diagnostics, Inc. (Princeton, NJ, USA). "Practices will now have an unprecedented opportunity to, first and foremost, offer expanded imaging services to their patients and, secondly, to improve the efficiency of their business. ICS and its wide array of services will be there to help them implement cardiac PET perfusion imaging every step of the way.”

Two recent clinical studies indicate that PET perfusion imaging is more accurate in the detection of coronary artery disease than the widely used single photon emission tomography (SPECT) perfusion imaging modality, particularly in women. Furthermore, the average time required for a cardiac PET perfusion test is about 30 minutes, versus three to four hours for the average cardiac SPECT perfusion scan, making cardiac PET more convenient for patients.

Cardiac PET perfusion imaging predominately uses the radionuclide rubidium-82, which can be derived from CardioGen-82 (rubidium Rb 82 generator), the only U.S Food and Drug Administration- (FDA)-approved generator-based cardiac PET perfusion agent. Over the past 18 months, the number of new CardioGen-82 sites has increased by nearly 90%. The adoption of cardiac PET in the outpatient setting is gaining favor among many cardiologists.

"I see ICS filling a missing piece in the rapidly emerging field of cardiac PET perfusion imaging. This venture will create a practical bridge, assisting practices in successfully implementing cardiac PET imaging as a significant and valued element in their patient management options,” stated Bill Abbott, vice president and general manager of nuclear medicine at Bracco Diagnostics.


Related Links:
Bracco Diagnostics
Integrated Cardiac Solutions

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.